'Knock down' of DNA polymerase beta by RNA interference: recapitulation of null phenotype

DNA polymerase beta (pol beta) is the major DNA polymerase involved in the base excision repair (BER) pathway in mammalian cells and, as a consequence, BER is severely compromised in cells lacking pol beta. Pol beta null (-/-) mouse embryos are not viable and pol beta null cells are hypersensitive to alkylating agents. Using RNA interference (RNAi) technology in mouse cells, we have reduced the pol beta protein and mRNA to undetectable levels. Pol beta knockdown cell lines display a pattern of hypersensitivity to DNA damaging agents similar to that observed in pol beta null cells. Generation of pol beta knock down cells makes it possible to combine the pol beta null phenotype with deficiencies in other DNA repair proteins, thereby helping to elucidate the role of pol beta and its interactions with other proteins in mammalian cells.     

DNA polymerase lambda protects mouse fibroblasts against oxidative DNA damage and is recruited to sites of DNA damage/repair

DNA polymerase lambda (pol lambda) is a member of the X family of DNA polymerases that has been implicated in both base excision repair and non-homologous end joining through in vitro studies. However, to date, no phenotype has been associated with cells deficient in this DNA polymerase. Here we show that pol lambda null mouse fibroblasts are hypersensitive to oxidative DNA damaging agents, suggesting a role of pol lambda in protection of cells against the cytotoxic effects of oxidized DNA. Additionally, pol lambda co-immunoprecipitates with an oxidized base DNA glycosylase, single-strand-selective monofunctional uracil-DNA glycosylase (SMUG1), and localizes to oxidative DNA lesions in situ. From these data, we conclude that pol lambda protects cells against oxidative stress and suggest that it participates in oxidative DNA damage base excision repair.     

Proliferating cell nuclear antigen (PCNA) as a proliferative marker during embryonic and adult zebrafish hematopoiesis

We investigated the expression of proliferative cell nuclear antigen (PCNA) in zebrafish to delineate the proliferative hematopoietic component during adult and embryonic hematopoiesis. Immunostaining for PCNA and enhanced green fluorescence protein (eGFP) was performed in wild-type and fli1-eGFP (endothelial marker) and gata1-eGFP (erythroid cell marker) transgenic fish. Expression of PCNA mRNA was examined in wild-type and chordin morphant embryos. In adult zebrafish kidney, the renal tubules are surrounded by endothelial cells and it is separated into hematopoietic and excretory compartments. PCNA was expressed in hematopoietic progenitor cells but not in mature neutrophils, eosinophils or erythroid cells. Some PCNA+ cells are scattered in the hematopoietic compartment of the kidney while others are closely associated with renal tubular cells. PCNA was also expressed in spermatogonial stem cells and intestine crypts, consistent with its role in cell proliferation and DNA synthesis. In embryos, PCNA is expressed in the brain, spinal cord and intermediate cell mass (ICM) at 24 h-post fertilization. In chordin morphants, PCNA is significantly upregulated in the expanded ICM. Therefore, PCNA can be used to mark cell proliferation in zebrafish hematopoietic tissues and to identify a population of progenitor cells whose significance would have to be further investigated.     

红背山麻杆叶的化学成分研究(Ⅱ)——黄酮和苯乙醇苷类化合物

采用80％丙酮提取物的水萃取部位,利用凝胶、MCI、反相碳18、及 Toyopearl Butyl-650C 柱色谱进行分离纯化得到7个黄酮和3个苯乙醇苷类化合物。根据化合物的波谱数据分析鉴定为槲皮素(1)、槲皮苷(2)、异懈皮苷(3)、芦丁(4)、异牡荆素(5)、牡荆素(6)、木犀草素-7-O-α-L-鼠李糖(1→6)-β-D-葡萄糖苷(7)、2-phenethylβ-D-glucoside(8)、icariside D1(9)、2-苯乙基-D-芸香甙(10)。其中化合物1-3、5-6、8-10为首次从本属植物中分离得到。     

The Escherichia coli Mismatch Repair Protein MutL Recruits the Vsr and MutH Endonucleases in Response to DNA Damage

The activities of the Vsr and MutH endonucleases of Escherichia coli are stimulated by MutL. The interaction of MutL with each enzyme is enhanced in vivo by 2-aminopurine treatment and by inactivation of the mutY gene. We hypothesize that MutL recruits the endonucleases to sites of DNA damage.The Escherichia coli Dcm protein methylates the second C of CCWGG sites (W = A or T). Deamination of 5-methylcytosine converts CG base pairs to T/G mismatches, causing CCWGG-to-CTWGG transition mutations. Very-short-patch (VSP) repair minimizes these mutations (2). Repair is initiated by a sequence- and mismatch-specific endonuclease, Vsr, which cleaves the DNA 5′ of the T. DNA polymerase I removes the T along with a few 3′ nucleotides and resynthesizes the missing bases, restoring the CG base pair. Vsr is both necessary and sufficient for initiating VSP repair. However, two other proteins, MutS and MutL, enhance VSP repair of deamination damage (1).MutS and MutL are best known for their roles in postreplication mismatch repair (MMR) (9, 11). MutL couples mismatch recognition by MutS to the activation of MutH, an endonuclease that cleaves the unmethylated strand of GATC sequences that are transiently hemimethylated following DNA replication. The nicked strand, containing the erroneous base, is removed by the UvrD helicase and one of several exonucleases to beyond the mismatch and then resynthesized by DNA polymerase III.MutL stimulates the endonuclease activities of both Vsr and MutH in vitro (8, 17). The requirements for stimulation are the same: a mismatch, MutS, and ATP hydrolysis by MutL (8, 8a). Cross-linking studies showed that MutH and Vsr interact with the same region in the N-terminal domain of MutL (Heinze et al., submitted). Competition of Vsr with MutH for access to MutL explains the ability of Vsr to inactivate MMR in vivo when overexpressed (6, 13). Thus, the interactions of the two repair endonucleases with MutL are structurally and functionally very similar.In contrast to MMR, where the cleavage site for MutH may be several kilobases away from the mismatch, VSP repair requires that mismatch recognition and endonucleolytic cleavage occur at the same C(T/G)WGG site. How MutS and MutL stimulate VSP repair if MutS and Vsr compete for the same mismatch remains unknown (2, 12). We hypothesized that MutS binds the mismatch first and that a MutS-MutL complex then recruits Vsr. If so, then the MMR proteins would initially mask the mismatch, making the interaction of Vsr with MutL independent of lesion identity.To test this hypothesis, we studied the interaction of MutL with Vsr and with MutH in response to two types of mismatch by using a bacterial two-hybrid assay (10). This assay detects all known interactions among the Mut proteins: homodimerization of MutS and MutL, interaction of MutL with MutS and with MutH, and interaction of Vsr with the N-terminal domain of MutL (15). We found no false positives or false negatives. Furthermore, since the assay relies on reconstitution of a soluble protein (adenylate cyclase), the DNA repair proteins are free to interact with the DNA (Fig. ​(Fig.11).Open in a separate windowFIG. 1.Known interactions among repair proteins as detected by the bacterial two-hybrid assay. The T18 and T25 subunits of CyaA are fused to any two repair proteins (illustrated here by MutL and Vsr), allowing measurement of all pairwise interactions as units of β-galactosidase (β-gal). T25 fusions are repair proficient. CRP, cyclic AMP (cAMP) receptor protein; P, lac operon promoter; RNAP, RNA polymerase.2-Aminopurine (2AP) mispairs with C during DNA replication, causing transition and frameshift mutations (5). The transitions are due primarily to the mismatch itself; the frameshifts are due to saturation of MMR, which leaves slipped-strand intermediates caused by DNA replication errors unrepaired (19). MutS and MutL bind to 2AP/C lesions (22), although the lesions may not be subject to MMR (19). As shown in Fig. ​Fig.2,2, treatment with 2AP causes a dose-dependent increase in the interaction of MutL with both Vsr and MutH; dimerization of MutL and interaction of MutL with MutS are somewhat increased.Open in a separate windowFIG. 2.Effect of 2AP treatment on protein-protein interactions in the bacterial two-hybrid assay. Results in units of β-galactosidase ± standard errors of the means (n = 9) are shown for BTH101(F galE15 ga1K16 rpsL1 hsdR2 mcrA1 mcrB1 cyaA-99) cells treated with 2AP as described previously (5, 19). Cells were cotransformed with pT18 and pT25 vectors (light gray bars), pT18-mutS and pT25-mutL (white bars), pT18-vsr and pT25-mutL (gray bars), pT18-mutH and pT25-mutL (black bars), or pT18-mutL and pT25-mutL (mottled bars). (NB: The dose-response curve for the pT18-mutS pT25-mutS transformants is similar to that of the pT18-mutL pT25-mutL transformants; it has been omitted for graphical clarity since the MutS-MutS interaction gives very high units of β-galactosidase activity [15]).The MutY adenine glycosylase removes A''s which have mispaired with oxidized guanine (8-oxoG) during DNA replication. Cells with a deletion of mutY have an elevated frequency of CG-to-AT transversion mutations (18); these are reduced by excess MutS, suggesting that 8-oxoG/A mismatches are also subject to MMR (23). As shown in Fig. ​Fig.3,3, the interactions between Vsr and MutL and between MutH and MutL increase in a mutY cell (stippled bars). Other interactions, such as MutS dimerization, are unaffected (not shown).Open in a separate windowFIG. 3.Effects of mutY and mutT deletions on protein-protein interactions in the bacterial two-hybrid assay. Results are in units of β-galactosidase, relative to the level in the wild type, in mutT (solid) and mutY (stippled) derivatives of BTH101 cotransformed with pT18 and pT25 vectors, pT18-mutH and pT25-mutL, pT18-vsr and pT25-mutL, or pT18-mutS and pT25-mutS (n = 3).8-OxoG/A mismatches also arise by incorporation of oxidized dGTP opposite A during DNA replication. The MutT nuclease minimizes this by removing oxidized dGTP from the nucleotide pool. The high frequency of AT-to-CG mutations in mutT strains is unaffected by the status of the MMR system (7, 21, 23), possibly because these 8-oxoG/A mispairs are in a conformation that MutS does not recognize. As shown in Fig. ​Fig.3,3, neither the interaction between MutL and Vsr nor that between MutL and MutH is elevated in a mutT strain (solid bars).These data show that mismatches which attract MutS and MutL increase the interaction of MutL with MutH in vivo. Although these mismatches are not subject to VSP repair, they also increase the interaction between MutL and Vsr. The simplest interpretation is that a MutS-MutL complex recruits MutH and Vsr to the DNA independent of the identity of the mismatch. MutS and MutL could then clear the mismatch, delivering the (activated) endonuclease to its specific target site, no matter how far away it is.Interaction of MutL with MutH, leading to MMR, is probably the default option. However, the MutS-MutL complex may recruit other repair proteins, such as Vsr or UvrB (20), to lesions that are poorly processed by MMR. The T/G mismatch in hemimethylated CTWGG sequences may be one such site. Vsr is expressed at very low levels in growing cells (14), so this recruitment would enhance VSP repair. However, recruitment of Vsr to other lesions would reduce VSP repair. For example, recruitment of Vsr by MutL to 2AP/C lesions (Fig. ​(Fig.2)2) could explain why CCWGG sites are hotspots for 2AP-induced mutations (4, 19).We have argued that Vsr is kept at low levels while DNA is replicating to avoid interference with MMR (14). However, if, as we suggest here, MutS and MutL are needed to recruit scarce Vsr to its target sequence, this argument loses its merit. It seems more likely that Vsr levels are kept low to avoid CTWGG-to-CCWGG mutations; Vsr creates these mutations by converting T/G mismatches formed at CTAGG sites by errors in DNA replication to CG (3, 6, 16). Vsr levels rise in nongrowing cells (14), when mutagenesis is no longer a risk. Under these circumstances, it is likely that MutS and MutL are no longer required for efficient VSP repair.     

Interaction between the mismatch repair and nucleotide excision repair pathways in the prevention of 5-azacytidine-induced CG-to-GC mutations in Escherichia coli

5-Azacytidine induces CG-to-GC transversion mutations in Escherichia coli. The results presented in this paper provide evidence that repair of the drug-induced lesions that produce these mutations involves components of both the mismatch repair and nucleotide excision repair systems. Strains deficient in mutL, mutS, uvrA, uvrB or uvrC all showed an increase in mutation in response to 5-azacytidine. Using a bacterial two-hybrid assay, we showed that UvrB interacts with MutL and MutS in a drug-dependent manner, while UvrC interacts with MutL independent of drug. We suggest that 5-azacytidine-induced mismatches recruit MutS and MutL, but are poorly processed by mismatch repair. Instead, the stalled MutS–MutL complex recruits the Uvr proteins to complete repair.     

Src Regulates the Activity of the ING1 Tumor Suppressor

The INhibitor of Growth 1 (ING1) is stoichiometric member of histone deacetylase (HDAC) complexes and functions as an epigenetic regulator and a type II tumor suppressor. It impacts cell growth, aging, apoptosis, and DNA repair, by affecting chromatin conformation and gene expression. Down regulation and mislocalization of ING1 have been reported in diverse tumor types and Ser/Thr phosphorylation has been implicated in both of these processes. Here we demonstrate that both in vitro and in vivo, the tyrosine kinase Src is able to physically associate with, and phosphorylate ING1, which results in a nuclear to cytoplasmic relocalization of ING1 in cells and a decrease of ING1 stability. Functionally, Src antagonizes the ability of ING1 to induce apoptosis, most likely through relocalization of ING1 and down regulation of ING1 levels. These effects were due to both kinase-dependent and kinase-independent properties of Src, and were most apparent at elevated levels of Src expression. These findings suggest that Src may play a major role in regulating ING1 levels during tumorigenesis in those cancers in which high levels of Src expression or activity are present. These data represent the first report of tyrosine kinase-mediated regulation of ING1 levels and suggest that kinase activation can impact chromatin structure through the ING1 epigenetic regulator.